Literature DB >> 9797262

Variable cross-resistance to Cry11B from Bacillus thuringiensis subsp. jegathesan in Culex quinquefasciatus (Diptera: Culicidae) resistant to single or multiple toxins of Bacillus thuringiensis subsp. israelensis.

M C Wirth1, A Delécluse, B A Federici, W E Walton.   

Abstract

A novel mosquitocidal bacterium, Bacillus thuringiensis subsp. jegathesan, and one of its toxins, Cry11B, in a recombinant B. thuringiensis strain were evaluated for cross-resistance with strains of the mosquito Culex quinquefasciatus that are resistant to single and multiple toxins of Bacillus thuringiensis subsp. israelensis. The levels of cross-resistance (resistance ratios [RR]) at concentrations which caused 95% mortality (LC95) between B. thuringiensis subsp. jegathesan and the different B. thuringiensis subsp. israelensis-resistant mosquito strains were low, ranging from 2.3 to 5.1. However, the levels of cross-resistance to Cry11B were much higher and were directly related to the complexity of the B. thuringiensis subsp. israelensis Cry toxin mixtures used to select the resistant mosquito strains. The LC95 RR obtained with the mosquito strains were as follows: 53.1 against Cq4D, which was resistant to Cry11A; 80.7 against Cq4AB, which was resistant to Cry4A plus Cry4B; and 347 against Cq4ABD, which was resistant to Cry4A plus Cry4B plus Cry11A. Combining Cyt1A with Cry11B at a 1:3 ratio had little effect on suppressing Cry11A resistance in Cq4D but resulted in synergism factors of 4.8 and 11.2 against strains Cq4AB and Cq4ABD, respectively; this procedure eliminated cross-resistance in the former mosquito strain and reduced it markedly in the latter strain. The high levels of activity of B. thuringiensis subsp. jegathesan and B. thuringiensis subsp. israelensis, both of which contain a complex mixture of Cry and Cyt proteins, against Cry4- and Cry11-resistant mosquitoes suggest that novel bacterial strains with multiple Cry and Cyt proteins may be useful in managing resistance to bacterial insecticides in mosquito populations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797262      PMCID: PMC106624     

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  21 in total

1.  Resistance to Toxins from Bacillus thuringiensis subsp. kurstaki Causes Minimal Cross-Resistance to B. thuringiensis subsp. aizawai in the Diamondback Moth (Lepidoptera: Plutellidae).

Authors:  B E Tabashnik; N Finson; M W Johnson; W J Moar
Journal:  Appl Environ Microbiol       Date:  1993-05       Impact factor: 4.792

2.  Cloning and characterization of a cytolytic and mosquitocidal delta-endotoxin from Bacillus thuringiensis subsp. jegathesan.

Authors:  H Cheong; S S Gill
Journal:  Appl Environ Microbiol       Date:  1997-08       Impact factor: 4.792

Review 3.  Bacillus sphaericus as a mosquito pathogen: properties of the organism and its toxins.

Authors:  P Baumann; M A Clark; L Baumann; A H Broadwell
Journal:  Microbiol Rev       Date:  1991-09

4.  Deletion by in vivo recombination shows that the 28-kilodalton cytolytic polypeptide from Bacillus thuringiensis subsp. israelensis is not essential for mosquitocidal activity.

Authors:  A Delécluse; J F Charles; A Klier; G Rapoport
Journal:  J Bacteriol       Date:  1991-06       Impact factor: 3.490

5.  Broad-spectrum resistance to Bacillus thuringiensis toxins in Heliothis virescens.

Authors:  F Gould; A Martinez-Ramirez; A Anderson; J Ferre; F J Silva; W J Moar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  Influence of Exposure to Single versus Multiple Toxins of Bacillus thuringiensis subsp. israelensis on Development of Resistance in the Mosquito Culex quinquefasciatus (Diptera: Culicidae).

Authors:  G P Georghiou; M C Wirth
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

7.  Toxicity of Bacillus thuringiensis Spore and Crystal Protein to Resistant Diamondback Moth (Plutella xylostella).

Authors:  J D Tang; A M Shelton; J Van Rie; S De Roeck; W J Moar; R T Roush; M Peferoen
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

8.  Development of Bacillus thuringiensis CryIC Resistance by Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae).

Authors:  W J Moar; M Pusztai-Carey; H Van Faassen; D Bosch; R Frutos; C Rang; K Luo; M J Adang
Journal:  Appl Environ Microbiol       Date:  1995-06       Impact factor: 4.792

9.  A new serovar of Bacillus thuringiensis possessing 28a28c flagellar antigenic structure: Bacillus thuringiensis serovar jegathesan, selectively toxic against mosquito larvae.

Authors:  P Seleena; H L Lee; M M Lecadet
Journal:  J Am Mosq Control Assoc       Date:  1995-12       Impact factor: 0.917

10.  Cloning and expression of a novel toxin gene from Bacillus thuringiensis subsp. jegathesan encoding a highly mosquitocidal protein.

Authors:  A Delécluse; M L Rosso; A Ragni
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

View more
  15 in total

1.  Evolution of Resistance in Culex quinquefasciatus (Say) Selected With a Recombinant Bacillus thuringiensis Strain-Producing Cyt1Aa and Cry11Ba, and the Binary Toxin, Bin, From Lysinibacillus sphaericus.

Authors:  Margaret C Wirth; William E Walton; Brian A Federici
Journal:  J Med Entomol       Date:  2015-08-04       Impact factor: 2.278

2.  The 60-kilodalton protein encoded by orf2 in the cry19A operon of Bacillus thuringiensis subsp. jegathesan functions like a C-terminal crystallization domain.

Authors:  J Eleazar Barboza-Corona; Hyun-Woo Park; Dennis K Bideshi; Brian A Federici
Journal:  Appl Environ Microbiol       Date:  2012-01-13       Impact factor: 4.792

3.  Effect of Promoters and Plasmid Copy Number on Cyt1A Synthesis and Crystal Assembly in Bacillus thuringiensis.

Authors:  Hyun-Woo Park; Robert H Hice; Brian A Federici
Journal:  Curr Microbiol       Date:  2015-09-22       Impact factor: 2.188

4.  Cyt1Aa from Bacillus thuringiensis subsp. israelensis is toxic to the diamondback moth, Plutella xylostella, and synergizes the activity of Cry1Ac towards a resistant strain.

Authors:  A H Sayyed; N Crickmore; D J Wright
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

5.  Immobilization of alginate-encapsulated Bacillus thuringiensis var. israelensis containing different multivalent counterions for mosquito control.

Authors:  G Prabakaran; S L Hoti
Journal:  Curr Microbiol       Date:  2008-04-04       Impact factor: 2.188

6.  Characterization and Whole Genome Sequencing of AR23, a Highly Toxic Bacillus thuringiensis Strain Isolated from Lebanese Soil.

Authors:  Nancy Fayad; Rafael Patiño-Navarrete; Zakaria Kambris; Mandy Antoun; Mike Osta; Joel Chopineau; Jacques Mahillon; Laure El Chamy; Vincent Sanchis; Mireille Kallassy Awad
Journal:  Curr Microbiol       Date:  2019-09-28       Impact factor: 2.188

7.  Aedes aegypti cadherin serves as a putative receptor of the Cry11Aa toxin from Bacillus thuringiensis subsp. israelensis.

Authors:  Jianwu Chen; Karlygash G Aimanova; Luisa E Fernandez; Alejandra Bravo; Mario Soberon; Sarjeet S Gill
Journal:  Biochem J       Date:  2009-11-11       Impact factor: 3.857

8.  Influence of amino nitrogen in the culture medium enhances the production of delta-endotoxin and biomass of Bacillus thuringiensis var. israelensis for the large-scale production of the mosquito control agent.

Authors:  G Prabakaran; S L Hoti
Journal:  J Ind Microbiol Biotechnol       Date:  2008-05-29       Impact factor: 3.346

9.  Alkaline phosphatases and aminopeptidases are altered in a Cry11Aa resistant strain of Aedes aegypti.

Authors:  Su-Bum Lee; Karlygash G Aimanova; Sarjeet S Gill
Journal:  Insect Biochem Mol Biol       Date:  2014-09-19       Impact factor: 4.714

10.  Achieving high coverage of larval-stage mosquito surveillance: challenges for a community-based mosquito control programme in urban Dar es Salaam, Tanzania.

Authors:  Prosper P Chaki; Nicodem J Govella; Bryson Shoo; Abdullah Hemed; Marcel Tanner; Ulrike Fillinger; Gerry F Killeen
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.